BesaGov

Contract W81K0024P0152

Alba Bioscience, Inc. · Department Of Defense · August 7, 2024

Small Business Set Aside - TotalFirm Fixed PriceNAICS 325413

Alba Bioscience, Inc. was awarded a federal contract by Department Of Defense (Department Of The Army) on August 7, 2024 for $86,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Jbsa Ft Sam Houston, TX. It was awarded under a small business set-aside. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 31, 2025. If all options are exercised, the contract could reach $423,000.

Obligated to date
$86.5K
$86,455
Current value
$249.7K
Potential value
$422.6K
if all options exercised
Modifications
3
Latest December 31, 2025

Contract details

PIID
W81K0024P0152
Award type
Purchase Order
Pricing
Firm Fixed Price
Set-aside
Small Business Set Aside - Total
Competition
Competed Under Sap
NAICS
325413 · In-Vitro Diagnostic Substance Manufacturing
Product / service
Drugs And Biologicals
Place of performance
Jbsa Ft Sam Houston, TX
First action
August 7, 2024
Latest action
December 31, 2025

Description

IN ACCORDANCE WITH FEDERAL ACQUISITION REGULATION (FAR) 52.232-18, AVAILABILITY OF FUNDS, FY26 FUNDS ARE AVAILABLE AND HEREBY OBLIGATED FOR PURCHASE ORDER W81K00-24-P-0152 FOR THE PERIOD OF 1 OCTOBER 2025 - 30 SEPTEMBER 2026.

Modification timeline

  • December 31, 2025
    Mod P00004 · Funding Only Action
    $163.2K
  • September 4, 2025
    Mod P00003 · Exercise An Option
    PURSUANT TO FEDERAL ACQUISITION REGULATION (FAR) 52.217-9, OPTION TO EXTEND THE TERM OF THE CONTRACT, W81K00-24-P-0152 WITH ALBA BIOSCIENCE, INC., IS HEREBY EXTENDED FOR THE PERIOD 01 OCTOBER 2025 - 3…
    $76.7K
  • August 29, 2025
    Mod P00002 · Supplemental Agreement For Work Within Scope
    DECREASE AND INCREASE IN REAGENTS.
    $76.7K
  • August 7, 2024
    Base award
    QC KIT (4X10ML) - IMMUNOHEMATOLOGY REAGENTS
    $0

Similar contracts

RecipientAgencyDateObligated
Diasorin IncDepartment Of DefenseDecember 31, 2025$518.8K
BloodworksDepartment Of DefenseDecember 31, 2025$160.2K
Sl Meditech Co.Department Of DefenseDecember 31, 2025$151.6K
Werfen USA LlcDepartment Of DefenseDecember 31, 2025$18.1K
Immucor IncDepartment Of DefenseDecember 31, 2025$154.2K
Quidelortho Sales Company, LlcDepartment Of DefenseDecember 30, 2025$505.8K

Top contractors in NAICS 325413

Lifetime obligated dollars across all federal contracts in this NAICS code.

#ContractorContractsObligated
1Biomerieux Inc182$25.50M
2Cepheid114$20.70M
3Roche Diagnostics Corporation125$13.00M
4Quest Diagnostics Incorporated8$4.31M
5Hologic Sales And Service, Llc39$3.88M
6Beckman Coulter, Inc28$3.40M
7Fisher Scientific Company L.L.C.52$3.04M
8Werfen USA Llc91$2.75M
9Diasorin Inc21$2.74M
10Abbott Laboratories Inc.10$2.69M

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract W81K0024P0152?

Contract W81K0024P0152 is a federal contract awarded to Alba Bioscience, Inc. by Department Of Defense on August 7, 2024 for $86,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 3 times since the base award.

Who won contract W81K0024P0152?

Alba Bioscience, Inc. won contract W81K0024P0152 from Department Of Defense.

How much is contract W81K0024P0152 worth?

Contract W81K0024P0152 has obligated $86,000 to date, with a total potential value of $423,000 if all options are exercised.